ACSRX
Price
$31.10
Change
+$0.16 (+0.52%)
Updated
Jul 3 closing price
Net Assets
12.82B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

ACSRX vs VIVAX

Header iconACSRX vs VIVAX Comparison
Open Charts ACSRX vs VIVAXBanner chart's image
Invesco Comstock R
Price$31.10
Change+$0.16 (+0.52%)
VolumeN/A
Net Assets12.82B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
ACSRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACSRX vs. VIVAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACSRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. ACSRX (12.8B). VIVAX pays higher dividends than ACSRX: VIVAX (2.06) vs ACSRX (1.31). ACSRX was incepted earlier than VIVAX: ACSRX (23 years) vs VIVAX (33 years). ACSRX (1.06) is less costly to investors than VIVAX (0.17). ACSRX is a more actively managed with annual turnover of: 18.00 vs. VIVAX (9.00). ACSRX has a lower initial minimum investment than VIVAX: ACSRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. ACSRX (7.17). VIVAX return over 5 years is better than : 80.14 vs. ACSRX (68.07).
ACSRXVIVAXACSRX / VIVAX
Total Expense Ratio1.060.17624%
Annual Report Gross Expense Ratio1.060.17624%
Fund Existence23 years33 years-
Gain YTD9.4186.209152%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.8B189B7%
Annual Yield % from dividends1.312.0663%
Returns for 1 year7.1712.0460%
Returns for 3 years18.1635.1652%
Returns for 5 years68.0780.1485%
Returns for 10 years36.99115.7432%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.